CURE High Drug Prices Act

United States116th CongressHR-4158House of Representatives
Updated: Aug 5, 2019

Summary

Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-637: CURE High Drug Prices Act

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  1. Introduced in House

  2. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.